| scholarly article | Q13442814 |
| P2093 | author name string | Vincent A Fischetti | |
| Assaf Raz | |||
| Chad W Euler | |||
| Anna Serrano | |||
| Anaise Hernandez | |||
| P2860 | cites work | Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. | Q54127746 |
| Corneal ulcers associated with contact lens wear | Q70944806 | ||
| Predominant pathogens found in the European Prevalence of Infection in Intensive Care Study | Q71470335 | ||
| Functional analysis of antibacterial activity of Bacillus amyloliquefaciens phage endolysin against Gram-negative bacteria | Q74128751 | ||
| Bacillus amyloliquefaciens phage endolysin can enhance permeability of Pseudomonas aeruginosa outer membrane and induce cell lysis | Q75233606 | ||
| Toxicity after prolonged (more than four weeks) administration of intravenous colistin | Q24798835 | ||
| Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections | Q26768034 | ||
| Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogens | Q28243174 | ||
| Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units | Q28248724 | ||
| NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007 | Q28298371 | ||
| Characterization of modular bacteriophage endolysins from Myoviridae phages OBP, 201φ2-1 and PVP-SE1 | Q28483710 | ||
| Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa | Q30581467 | ||
| Efficacy of Artilysin Art-175 against Resistant and Persistent Acinetobacter baumannii. | Q30761262 | ||
| Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria | Q33735389 | ||
| Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist | Q34019954 | ||
| Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens | Q34114172 | ||
| A bacteriolytic agent that detects and kills Bacillus anthracis | Q34145707 | ||
| Lysins: the arrival of pathogen-directed anti-infectives | Q34354452 | ||
| A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains | Q34528933 | ||
| Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections | Q34560321 | ||
| Otitis externa: Review and clinical update. | Q34572626 | ||
| Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model | Q35168859 | ||
| Agents that increase the permeability of the outer membrane. | Q35403079 | ||
| Novel Engineered Peptides of a Phage Lysin as Effective Antimicrobials against Multidrug-Resistant Acinetobacter baumannii. | Q36887978 | ||
| Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus | Q37026612 | ||
| Improving the lethal effect of cpl-7, a pneumococcal phage lysozyme with broad bactericidal activity, by inverting the net charge of its cell wall-binding module | Q37263537 | ||
| Update on the treatment of Pseudomonas aeruginosa pneumonia | Q37516904 | ||
| Pseudomonas aeruginosa: host defence in lung diseases | Q37781114 | ||
| Pseudomonas genomes: diverse and adaptable | Q37848453 | ||
| Phage lysis: three steps, three choices, one outcome | Q38192505 | ||
| Bactericidal action of lysozymes attached with various sizes of hydrophobic peptides to the C-terminal using genetic modification | Q38342229 | ||
| Pseudomonas aeruginosa outer membrane permeability: isolation of a porin protein F-deficient mutant | Q39975123 | ||
| A simple method of mouse lung intubation | Q40230954 | ||
| Lung surfactant: a personal perspective | Q40914034 | ||
| Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres | Q43644594 | ||
| Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase | Q43820230 | ||
| Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? | Q43874264 | ||
| Antibacterial activity of Acinetobacter baumannii phage ϕAB2 endolysin (LysAB2) against both gram-positive and gram-negative bacteria | Q45720461 | ||
| In vitro characterization of PlyE146, a novel phage lysin that targets Gram-negative bacteria. | Q48097789 | ||
| Enhanced bactericidal action of lysozyme to Escherichia coli by inserting a hydrophobic pentapeptide into its C terminus. | Q52514128 | ||
| P433 | issue | 7 | |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| skin infection | Q2458539 | ||
| P577 | publication date | 2019-06-24 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Isolation of Phage Lysins That Effectively Kill Pseudomonas aeruginosa in Mouse Models of Lung and Skin Infection | |
| P478 | volume | 63 |
| Q89517214 | Antibody Binding to the O-Specific Antigen of Pseudomonas aeruginosa O6 Inhibits Cell Growth |
| Q96304085 | Bacteriophages, a New Therapeutic Solution for Inhibiting Multidrug-Resistant Bacteria Causing Wound Infection: Lesson from Animal Models and Clinical Trials |
| Q89697787 | Gram-Negative Bacterial Lysins |
| Q94452171 | In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens |
Search more.